Public listing of Serodus ASA at Oslo Axess

Applied date: 20/02/2013
Accepted date: 20/03/2013
Listing date: 09/04/2013
Ticker: SER

Serodus is focused on development of drugs for treatment of diseases in the heart and blood vessels. Drug candidates from Serodus will benefit the patients by improved clinical therapeutic outcome and thereby enhance quality of life and improve prognosis for patients with cardio-vascular diseases.



Contact us

Linn Cathrin Slettedal